International Journal of Scientific and Research Publications

IJSRP, Volume 6, Issue 1, January 2016 Edition [ISSN 2250-3153]


Recent Developments in Aplastic Anemia Therapy
      Hussein Balfaqih, Mohsen Al-Shawrbji, Mohammed Bakudah
Abstract: Recent advances in the treatment of aplastic anemia (AA) made most of patients to expect to achieve a long-term survival. Allogeneic stem cell transplantation (SCT) from HLA-matched sibling donor (MSD-SCT) is a preferred first-line treatment option for younger patients with severe or very severe AA, whereas immunosup pressive treatment (IST) is an alternative option for others. Horse anti-thymocyte globuline (ATG) with cyclosporin A (CsA) had been a standard IST regimen with acceptable response rate. Recently, horse ATG had been not available and replaced with rabbit ATG in most countries.

Reference this Research Paper (copy & paste below code):

Hussein Balfaqih, Mohsen Al-Shawrbji, Mohammed Bakudah (2018); Recent Developments in Aplastic Anemia Therapy; Int J Sci Res Publ 6(1) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0116.php?rp=P494986
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.